Prior to joining Nextech in 2018, Dr. Diez worked as a Postdoctoral Researcher at University Children’s Hospital Zurich, where she specialized on the development of novel therapies for metabolic rare disorders and cancer. In parallel, she worked part time as private equity analyst at HBM Partners (Switzerland). She received the M.Sc. degree in Medical Biotechnology and Ph.D in Biotechnology from Universidad Politécnica de Valencia, Spain. Throughout her studies, she gained international experience in specific areas of biomedicine at KTH Biotechnology (with Prof. Mathias Uhlén), Bergen University and University Children’s Hospital Zurich (Switzerland).